As of May 2026 — Disclosed Capitol has tracked 21 disclosed congressional trades in Dolby Laboratories, Inc. (DLB) — 9:6 sell-heavy ratio — led by Ro Khanna (D).

Which members of Congress trade Dolby Laboratories, Inc.?

• Ro Khanna (D) — 5 disclosed trades in DLB
• Lisa McClain (R) — 4 disclosed trades in DLB
• Jim Renacci (R) — 4 disclosed trades in DLB
• Michael McCaul (R) — 3 disclosed trades in DLB
• Thomas MacArthur (R) — 3 disclosed trades in DLB

Recent DLB congressional trades

Buy vs. sell ratio & volume

Across the 21 disclosed congressional trades in Dolby Laboratories, Inc. (DLB), members of Congress have reported 6 buys and 9 sells. The average 30-day alpha vs. the S&P 500 is 0.18%.

Are Dolby Laboratories, Inc. insiders buying or selling DLB?

As of August 2026, corporate insiders at Dolby Laboratories, Inc. have filed 11 SEC Form 4 transactions in DLB over the past 12 months — including 7 sells worth $1.2M.

Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.

Dolby Laboratories, Inc. financial snapshot (FY2025)

For fiscal year 2025, Dolby Laboratories, Inc. reported revenue of $1.35B and net income of $255.0M, per SEC filings.

Revenue

$1.35B

Gross profit

$1.19B

Operating income

$265.0M

Net income

$255.0M

Diluted EPS

$2.62

Gross margin

88.1%

Net margin

18.9%

Free cash flow

$435.9M

Most recent reported quarter: Q3 FY2026 — revenue $305.0M, net income $28.6M.

Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.